Development and in vivo imaging of a PET/MRI nanoprobe with enhanced NIR fluorescence by dye encapsulation

Nanomedicine

Volumn 7, Issue 2, 2012, Pages 219-229

  Kim, Jun Sung ^a   Kim, Young Hwa ^b   Kim, Jin Hyun ^a   Kang, Keon Wook ^b,c   Tae, Eunju Lee ^a   Youn, Hyewon ^b,c   Kim, Daehong ^d   Kim, Seok Ki ^d   Kwon, Jung Taek ^e   Cho, Myung Haing ^e   Lee, Yun Sang ^b   Jeong, Jae Min ^b   Chung, June Key ^b,c   Lee, Dong Soo ^b,e  

^a Biterials Co Ltd   (South Korea)

^b Seoul National University   (South Korea)

^c Seoul National University Hospital   (South Korea)

^d National Cancer Center   (South Korea)

^e Seoul National University   (South Korea)

Author keywords

magnetic resonance imaging; magnetic silica nanoparticles; multimodal in vivo imaging; near infrared fluorescence; positron emission tomography

Indexed keywords

DYE; NANOPARTICLE; RADIOISOTOPE; SILICON DIOXIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENCAPSULATION; FEMALE; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IMAGE ENHANCEMENT; IN VIVO STUDY; MOUSE; NANOPROBE; NEAR INFRARED SPECTROSCOPY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENTINEL LYMPH NODE; SURFACE PROPERTY;

CELL LINE, TUMOR; CELL TRACKING; COLORING AGENTS; CONTRAST MEDIA; HUMANS; LUNG NEOPLASMS; MICROSCOPY, FLUORESCENCE; MOLECULAR IMAGING; MOLECULAR PROBE TECHNIQUES; NANOCAPSULES; POSITRON-EMISSION TOMOGRAPHY; SPECTROSCOPY, NEAR-INFRARED;

EID: 84863127412     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.11.94     Document Type: Article

References (41)

1. Sun C, Veiseh O, Gunn J et al. In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes. Small 4(3), 372-379 (2008).
2. Terreno E, Castelli DD, Viale A, Aime S. Challenges for molecular magnetic resonance imaging. Chem. Rev. 110(5), 3019-3042 (2010).
3. Frullano L, Meade TJ. Multimodal MRI contrast agents. J. Biol. Inorg. Chem. 12(7), 939-949 (2007).
4. Kim J, Kim HS, Lee N et al. Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery. Angew. Chem. Int. Ed. Engl. 120(44), 8566-8569 (2008).
5. Nahrendorf M, Sosnovik DE, Waterman P et al. Dual channel optical tomographic imaging of leukocyte recruitment and protease activity in the healing myocardial infarct. Circ. Res. 100(8), 1218-1225 (2007).
6. Rieter WJ, Kim JS, Taylor KML et al. Hybrid silica nanoparticles for multimodal imaging. Angew. Chem. Int. Ed. Engl. 46(20), 3680-3682 (2007).
7. Lee JH, Jun YW, Yeon SI, Shin JS, Cheon J. Dual-mode nanoparticle probes for high-performance magnetic resonance and fluorescence imaging of neuroblastoma. Angew. Chem. Int. Ed. Engl. 118(48), 8340-8342 (2006).
8. Josephson L, Kircher MF, Mahmood U, Tang Y, Weissleder R. Near-infrared fluorescent nanoparticles as combined MR/Optical imaging probes. Bioconjugate Chem. 13(3), 554-560 (2002).
9. Olson ES, Jiang T, Aguilera TA, Nguyen QT, Ellies LG. Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases. Proc. Natl Acad. Sci. USA 107(9), 4311-4316 (2010).
10. Sampath L, Kwon S, Ke S et al. Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer. J. Nucl. Med. 48(9), 1501-1510 (2007).
11. Cai W, Chen K, Li ZB, Gambhir SS, Chen X. Dual-function probe for PET and near-infrared fluorescence imaging of tumor vasculature. J. Nucl. Med. 48(11), 1862-1870 (2007).
12. Petrovsky A, Schellenberger E, Josephson L, Weissleder R, Bogdanov A Jr. Near-infrared fluorescent imaging of tumor apoptosis. Cancer Res. 63(8), 1936-1942 (2003).
13. Burns AA, Vider J, Ow H et al. Fluorescent silica nanoparticles with efficient urinary excretion for nanomedicine. Nano Lett. 9(1), 442-448 (2009).
14. Jeon YH, Kim YH, Choi K et al. In vivo imaging of sentinel nodes using fluorescent silica nanoparticles in living mice. Mol. Imaging Biol. 12(2), 155-162 (2010).
15. Nguyen QT, Olson ES, Aguilera TA et al. Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival. Proc. Natl Acad. Sci. USA 107(9), 4317-4322 (2010).
16. Kim S, Lim YT, Soltesz EG et al. Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat. Biotech. 22(1), 93-97 (2004).
17. Kim SW, Zimmer JP, Ohnishi S, Tracy JB, Frangioni JV, Bawendi MG. Engineering InAs(x)P(1-x)/InP/ZnSe III-V alloyed core/ shell quantum dots for the near-infrared. J. Am. Chem. Soc. 127(3), 10526-10532 (2005).
18. Troyan SL, Kianzad V, Gibbs-Strauss SL et al. The FLARE intraoperative near-infrared fluorescence imaging system; a first-in-human clinical trial Ann. Surg. Oncol. 16(10), 2943-2952 (2009).
19. Hwang DW, Ko HY, Lee JH. A nucleolin-targeted multimodal nanoparticle imaging probe for tracking cancer cells using an aptamer. J. Nucl. Med. 51(1), 98-105 (2010).
20. Stelter L, Pinkernelle JG, Michel R et al. Modification of aminosilanized superparamagnetic nanoparticles: feasibility of multimodal detection using 3T MRI, small animal PET, and fluorescence imaging. Mol. Imaging Biol. 12(1), 25-34 (2010).
21. Wagner DS, Delk NA, Lukianova-Hleb EY, Hafner JH, Farach-Carson MC, Lapotko DO. The in vivo performance of plasmonic nanobubbles as cell theranostic agents in zebrafish hosting prostate cancer xenografts. Biomaterials 31(29), 7567-7574 (2010).
22. Zins D, Cabuil V, Massart R. New aqueous magnetic fluids. J. Mol. Liq. 83(1), 217-232 (1999).
23. Sousa MH, Tourinho FA, Depeyrot J, da Silva GJ, Lara MCFL. New electric double-layered magnetic fluids based on copper, nickel, and zinc ferrite nanostructures. J. Phys. Chem. B 105(6), 1168-1175 (2001).
24. Pham W, Lai WF, Weissleder R, Tung CH. High efficiency synthesis of a bioconjugatable near-infrared fluorochrome. Bioconjugate Chem. 14(5), 1048-1051 (2003).
25. Choi JS, Park JC, Nah H et al. A hybrid nanoparticle probe for dual-modality positron emission tomography and magnetic resonance imaging. Angew. Chem. Int. Ed. Engl. 120(33), 6355-6358 (2008).
26. Judenhofer MS, Wehrl HF, Newport DF et al. Simultaneous PET-MRI: A new approach for functional and morphological imaging. Nat. Med. 14(4), 459-465 (2008).
27. Stöber W, Fink A, Bohn E. Controlled growth of monodisperse silica spheres in the micron size range. J. Colloid Interface Sci. 26(1), 62-69 (1968).
28. Piao Y, Burns A, Kim J, Wiesner U, Hyeon T. Designed fabrication of silica-based nanostructured particle systems for nanomedicine applications. Adv. Funct. Mater. 18(23), 3745-3758 (2008).
29. Sharma P, Brown S, Walter G, Santra S, Moudgil B. Nanoparticles for bioimaging. Adv. Colloid Interface Sci. 123, 471-485 (2006).
30. Graf C, Vossen DLJ, Imhof A, van Blaaderen A. A general method to coat colloidal particles with silica. Langmuir 19(17), 6693-6700 (2003).
31. Gupta AK, Naregalkar RR, Vaidya VD, Gupta M. Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical application. Nanomedicine 2(1), 23-39 (2007).
32. Ow H, Larson DR, Srivastava M, Baird BA, Webb WW, Wiesner U. Bright and stable core-shell fluorescent silica nanoparticles. Nano Lett. 5(1), 113-117 (2005).
33. Larson DR, Ow H, Vishwasrao HD, Heikal AA, Wiesner U, Webb WW. Silica nanoparticle architecture determines radiativeproperties of encapsulated fluorophores. Chem. Mater. 20(20), 2677-2684 (2008).
34. Pham W, Lai WF, Weissleder R, Tung CH. High efficiency synthesis of a bioconjugatable near-infrared fluochrome. Bioconjugate Chem. 14(5), 1048-1051 (2003).
35. Park KS, Tae J, Choi B, Kim YS, Moon C. Characterization, in vitro cytotoxicity assessment, and in vivo visualization of multimodal, RITC-labeled, silica-coated magnetic nanoparticles for labeling human cord blood-derived mesenchymal stem cells. Nanomedicine 6(2), 263-276 (2010).
36. Seok JW, Kim IJ. Camparison of the efficiency for Tc-99m Tin-colloid and Tc-99m phytate in sentinel node detection in breast cancer patients. Nucl. Med. Mol. Imaging 42(6), 451-455 (2008).
37. Jang SJ, Moon SH, Kim SK et al. Comparison of the results for sentinel lymph node mapping in the breast cancer patients using 99mTc-antimony trisulfide colloid, 99mTc-Tin colloid, and 99mTc-human serum albumin. Nucl. Med. Mol. Imaging 41(6), 546-552 (2007).
38. Lee S, Kim EY, Kang SH et al. Sentinel node identification rate, but not accuracy, is significantly decreased after pre-operative chemotherapy in axillary node-positive breast cancer patients. Breast Cancer Res. Treat.102(3), 283-288 (2007).
39. Kobayashi H, Kawamoto S, Bernardo M et al. Delivery of gadolinium-labeled nanoparticles to the sentinel lymph node: comparison of the sentinel node visualization and estimations of intra-nodal gadolinium concentration by the magnetic resonance imaging. J. Control Release 111(3), 343-351 (2006).
40. Nakajima M, Takeda M, Kobayashi M, Suzuki S, Ohuchi N. Nano-sized fluorescent particles as new tracers for sentinel node detection: experimental model for decision of appropriate size and wavelength. Cancer Sci. 96(6), 353-356 (2005).
41. Antoch G, Bockisch A. Combined PET/MRI: A new dimension in whole-body oncology imaging? Eur. J. Nucl. Med. Mol. Imaging 36(Suppl. 1), S113-S120 (2009).